Cardiac cachexia is a multifaceted and severe syndrome characterized by the involuntary weight loss, muscle wasting, and debility seen in individuals grappling with chronic heart failure. This syndrome extends beyond simple weight reduction, involving a profound depletion of both lean body mass and fat reserves. Its management presents a considerable challenge in the context of heart failure, often resulting in heightened morbidity and mortality rates. The intricate mechanisms underlying cardiac cachexia encompass a intricate interplay of inflammatory processes, hormonal imbalances, and metabolic disruptions. Clinically, individuals afflicted by cardiac cachexia witness a decline in their functional capacity, coupled with a compromised quality of life. Approaches to managing this syndrome typically necessitate a multidisciplinary strategy, emphasizing nutritional support, exercise rehabilitation, and addressing the root causes of heart failure. Ongoing research delving into the pathophysiology and treatment avenues for cardiac cachexia aspires to deepen our comprehension and enhance the prognosis for those affected by this incapacitating syndrome.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine